Zhuhai Livzon Pharmaceutical Equity Investment Management Co., Ltd.

Overview

As the investment arm of Livzon Pharmaceutical Group Inc., Zhuhai Livzon Pharmaceutical Equity Investment Management Co., Ltd. specializes in the life and health sectors. The company engages in private equity and venture capital investments, targeting early-stage to pre-IPO companies, as well as buyouts. Its geographical focus includes China, the United States, and Vietnam, with a particular emphasis on the pharmaceutical, biotechnology, diagnostics, medical devices, and healthcare services industries. Investment sizes range from $5 million to $50 million. The firm has a history of strategic investments, such as acquiring a 5% stake in Zhuhai Livzon Diagnostics Inc. in November 2023, and a 3% stake from Li Lin in the same month. Additionally, in May 2025, Livzon Pharmaceutical Group announced plans to acquire a controlling stake in Vietnam's Imexpharm for approximately $220.7 million, marking a significant expansion into the Vietnamese market. These investments reflect the firm's commitment to enhancing its portfolio in the life and health sectors, both domestically and internationally.